A G E N D A

The National Collegiate Athletic Association

Committee on Competitive Safeguards and Medical Aspects of Sports

Drug-Education and Drug-Testing Subcommittee

Hilton Gaslamp Quarter Hotel June 20-21, 2003

San Diego, California

1. Introduce new members and review agenda.

2. Approve December 15, 2002, meeting minutes. [Supplement No. 1]

3. Follow-up of recent relevant governance actions. [Supplement No. 2]

4. Report from The National Center for Drug Free Sport. [Supplement No. 3 to be distributed at the meeting.] (Frank Uryasz and Andrea Wickerham)

5. Changes to banned substance list. [Supplement No. 4]

· Synephrine. [Supplement No. 5]

6. Recommended drug-testing protocol changes.

· Specimen security seal and protocol 8.2.2.4. [Supplement No. 6]

7. Appeal process and medical exception process.

a. Quorum. [Supplement No. 7]

b. Exception for banned medications not included in drug-test panel. [Supplement No. 8] (Uryasz)

c. Releasing precedent information. [Supplement No. 9] (Elsa Cole and Wickerham)

d. Appeal decisions rationale. [Supplement No. 10] (Wickerham)

e. Two-to-one appeal decisions.

f. Response to Matt Mitten's letter regarding expanded appeal decision report to an institution. [Supplement No. 11]

g. Review appeal evaluation form. [Supplement No. 12] (Wickerham)

8. Drug-testing forms review.

a. Consent form. [Supplement No. 13]

b. Student-athlete statement. [Supplement No. 14]

9. Drug-testing issues.

a. Update on drug testing. [Supplement No. 15] (Gary Green)

b. Graduated Penalties. [Refer to Supplement No. 5 in the Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) agenda] (Mazur)

c. Testing products for contamination. [Supplement No. 16]

d. Street-drugs testing.

(1) Sanctions for second positive drug test. [Supplement No. 17]

(2) Year-round testing program.

e. All-sports drug-testing plan. [Supplement No. 18]

f. Specimen ownership. [Supplement No. 19] (Wickerham)

g. Retention of drug-test records. [Supplement No. 20] (Uryasz)

h. Competing unattached interpretation. [Supplement No. 21]

10. Drug-Education and Drug-Testing legislation.

a. Second positive drug test. [Refer to Supplement No. 17]

b. Institutional responsibility for NCAA drug-testing arrangements. [Supplement No. 22]

c. Divisions II and III nutritional supplements as impermissible benefits legislation. [Supplement No. 23]

11. Alcohol issues.

a. Techniques for Effective Alcohol Management (TEAM) on Campus update. [Supplement No. 24]

b. 2002-03 Speakers Grants.

· Approved programs and evaluations. [Supplement No. 25]

c. Athletic Prevention Programming and Leadership Education (APPLE) conferences report. [Supplement No. 26 to be distributed at the meeting.] (Paige Hawkins)

d. CHOICES report.

(1) Program expansion recommendation. [Supplement No. 27]

(2) Program evaluation recommendation. [Supplement No. 28]

(3) 2003 CHOICES awards. [Supplement No. 29]

e. Betty Ford Professional in Residence Program evaluations and review. [Supplement No. 30] (Rittgers)

12. Tobacco issues.

a. College World Series and National Spit Tobacco Education Project. [Supplement No. 31]

b. National Collegiate Tobacco Symposium. [Supplement No. 32]

c. Baseball Rules Committee resolution. [Supplement No. 33]

d. Umpires survey. [Supplement No. 34] (Uryasz)

13. Nutritional supplements issues.

a. Coalition for Anabolic Steroid Precursor and Ephedrine Regulation (CASPER). [Supplement No. 35]

b. Pharmanex request. [Supplement No. 36]

c. Topical agents. [Supplement No. 37]

d. CSMAS chair's response to the Food and Drug Administration regarding ephedrine restrictions. [Supplement No. 38] (Matt Mitten)

e. NCAA president’s response to congress on ephedra. [Supplement No. 39]

f. NCAA president’s response to the BlueCross BlueShield Association. [Supplement No. 40]

g. Actions to remove ephedra products – National Council Against Health Fraud. [Supplement No. 41]

h. Nutritional Supplement review form. [Supplement No. 42]

i. Football Issue Committee request for recommendation on nutritional supplement use.

14. Other drug issues.

· Illicit adderral use. [Supplement No. 43]

15. Outreach opportunities.

a. Inter-Association Task Force (IATF). [Supplement No. 44 to be distributed at the meeting]

b. U.S. Department of Education National Meeting. [Supplement No. 45]

16. Research data and opportunities.

a. DEDT Survey. [Supplement No. 46] (Denise DeHass)

b. Drug Use Survey Review. [Supplement No. 47] (DeHass)

17. Review drug-education budget for reallocation. [Supplement No. 48]

18. Recommend new or expanded Association-wide budget initiatives. [Refer to Supplement No. 28 in the CSMAS agenda.]

19. Recommend topics and articles for Health and Safety Newsletter.

20. Articles of interest. [Supplement No. 49]

a. Deadly Fuel.

b. Steroids Apparently Still Lurking in College Locker Rooms.

c. New Over-the-Counter Steroids Anger U.S. Officials.

d. Ephedra on Campus: Tackling the Controversy.

e. Study: School Drug Testing Doesn’t Deter Drug Use.

21. Sports Sciences Safety Subcommittee agenda. [Supplement No. 50]

22. Other issues.

23. Adjournment.